Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Bolsa de Madrid  >  FAES Farma SA    FAE   ES0134950F36

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Bolsa De Madrid
02/21/2017 02/22/2017 02/23/2017 02/24/2017 02/27/2017 Date
3.365(c) 3.39(c) 3.37(c) 3.33(c) 3.36 Last
184 411 334 614 217 680 174 471 452 259 Volume
+0.45% +0.74% -0.59% -1.19% +0.90% Change
More quotes
Financials (€)
Sales 2016 227 M
EBIT 2016 46,0 M
Net income 2016 37,0 M
Finance 2016 49,6 M
Yield 2016 1,52%
Sales 2017 248 M
EBIT 2017 56,0 M
Net income 2017 39,0 M
Finance 2017 70,4 M
Yield 2017 2,12%
P/E ratio 2016 23,32
P/E ratio 2017 20,71
EV / Sales2016 3,62x
EV / Sales2017 3,23x
Capitalization 871 M
More Financials
Company
Faes Farma SA engages in the manufacture, marketing, and research of pharmaceutical products and raw materials for pharmaceutical use. Its products are for allergies, antihypertensive, dermatological, diabetes, digestive, otorhinolaryngology, osteoarticular, respiratory, women's health, central... 
Sector
Pharmaceuticals
Calendar
05/17Earnings Release
More about the company
Surperformance© ratings of FAES Farma SA
Trading Rating : Investor Rating :
More Ratings
Latest news on FAES FARMA SA
2016 FAES FARMA SA : ex-dividend day for final dividend
2015 FAES FARMA SA : ex-dividend day for final dividend
2015 FAES FARMA : Statement 05/18/2015 (39 k.). Faes Farma has licensed a pharmaceuti..
2015 FAES FARMA : Comunicado 05/01/2015 (59 k.). Dividendo flexible. Datos de cierre ..
2015 FAES FARMA : Statement 02/27/2015 (81 k.). Faes Farma increases its net probit b..
2014 FAES FARMA : Statement 05/14/2014 (112 k.). Bilastine in Canada: signing of a li..
2014 FAES FARMA : Statement 05/14/2014 (112 k.). Bilastine in Canada: signing of a li..
2013 FAES FARMA SA : Statement 07/24/2013 (24 k.). January-June results.
2012 FAES FARMA SA : Statement 13/12/2012 (20 k). Faes Farma licences bilastine for S..
2012 FAES FARMA SA : Statement 02/07/2012 (19 k). FAES FARMA S.A. informs of the appr..
More news
Sector news : Pharmaceuticals - NEC
09:38pDJJOHNSON & JOHNSON : Prescription Unit List Prices Rose 8.5% Last Year
06:13p FTSE ends higher on some positive earnings, insurers slip
08:06aDJSANOFI : Lonza to Invest CHF290 Million in New Plant in Switzerland
02/24DJSHIRE : Files 8K - Other Events
02/24DJASTRAZENECA : Hyperkalaemia Drug Clears Scientific Hurdle for European Approval
More sector news : Pharmaceuticals - NEC
Latest Tweets
2015#Spain: Faes Farma : #Market Analysts predicted Oct 2015 sales growth & p.. 
2015#Frankfurt #stocks: Faes Farma : #Merger #Acquisition Analysts say: soft Aug .. 
2015Faes Farma desembarca en China mediante una 'joint venture' con Eddingpharm  
2015BRIEF-Faes Farma reaches license agreement for its product in USA  
2015#Frankfurt #stocks: Faes Farma : #Market Analysts conclude meagre sales profi.. 
More tweets
Qtime:25
Advertisement
Chart FAES FARMA SA
Duration : Period :
FAES Farma SA Technical Analysis Chart | FAE | ES0134950F36 | 4-Traders
Full-screen chart
Technical analysis trends FAES FARMA SA
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 7
Average target price 3,28 €
Spread / Average Target -1,4%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Gonzalo López Casanueva Co-Managing Director
Francisco Quintanilla Guerra Co-Managing Director
Mariano Ucar Angulo Chairman
Valentín Ruiz Unamunzaga Deputy MD & Director-Corporate Finance
Isidro Hermo Blanco Manager-Pharmaceutical Technology
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
FAES FARMA SA-0.89%919
JOHNSON & JOHNSON6.53%333 891
ROCHE HOLDING LTD.5.42%210 192
PFIZER INC.5.48%207 902
NOVARTIS AG4.72%202 648
MERCK & CO., INC.12.38%182 412
More Results